These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 27225760)

  • 1. Loss of Homeostasis in the Direct Pathway in a Mouse Model of Asymptomatic Parkinson's Disease.
    Escande MV; Taravini IR; Zold CL; Belforte JE; Murer MG
    J Neurosci; 2016 May; 36(21):5686-98. PubMed ID: 27225760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct pathway neurons in mouse dorsolateral striatum in vivo receive stronger synaptic input than indirect pathway neurons.
    Filipović M; Ketzef M; Reig R; Aertsen A; Silberberg G; Kumar A
    J Neurophysiol; 2019 Dec; 122(6):2294-2303. PubMed ID: 31618095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Striatal dysfunction increases basal ganglia output during motor cortex activation in parkinsonian rats.
    Belluscio MA; Riquelme LA; Murer MG
    Eur J Neurosci; 2007 May; 25(9):2791-804. PubMed ID: 17561844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Striatal Direct and Indirect Pathway Output Structures Are Differentially Altered in Mouse Models of Huntington's Disease.
    Barry J; Akopian G; Cepeda C; Levine MS
    J Neurosci; 2018 May; 38(20):4678-4694. PubMed ID: 29691329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopaminergic treatment weakens medium spiny neuron collateral inhibition in the parkinsonian striatum.
    Wei W; Ding S; Zhou FM
    J Neurophysiol; 2017 Mar; 117(3):987-999. PubMed ID: 27927785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of Striatal Cholinergic Interneurons and M1 and M4 Muscarinic Receptors in Motor Symptoms of Parkinson's Disease.
    Ztaou S; Maurice N; Camon J; Guiraudie-Capraz G; Kerkerian-Le Goff L; Beurrier C; Liberge M; Amalric M
    J Neurosci; 2016 Aug; 36(35):9161-72. PubMed ID: 27581457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant Striatal Activity in Parkinsonism and Levodopa-Induced Dyskinesia.
    Ryan MB; Bair-Marshall C; Nelson AB
    Cell Rep; 2018 Jun; 23(12):3438-3446.e5. PubMed ID: 29924988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Striatopallidal Neuron NMDA Receptors Control Synaptic Connectivity, Locomotor, and Goal-Directed Behaviors.
    Lambot L; Chaves Rodriguez E; Houtteman D; Li Y; Schiffmann SN; Gall D; de Kerchove d'Exaerde A
    J Neurosci; 2016 May; 36(18):4976-92. PubMed ID: 27147651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered function of glutamatergic cortico-striatal synapses causes output pathway abnormalities in a chronic model of parkinsonism.
    Warre R; Thiele S; Talwar S; Kamal M; Johnston TH; Wang S; Lam D; Lo C; Khademullah CS; Perera G; Reyes G; Sun XS; Brotchie JM; Nash JE
    Neurobiol Dis; 2011 Mar; 41(3):591-604. PubMed ID: 20971190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preserved Motility after Neonatal Dopaminergic Lesion Relates to Hyperexcitability of Direct Pathway Medium Spiny Neurons.
    Keifman E; Coll C; Tubert C; Paz RM; Belforte JE; Murer MG; Braz BY
    J Neurosci; 2022 Nov; 42(47):8767-8779. PubMed ID: 36241384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Network degeneration in Parkinson's disease: multimodal imaging of nigro-striato-cortical dysfunction.
    Ruppert MC; Greuel A; Tahmasian M; Schwartz F; Stürmer S; Maier F; Hammes J; Tittgemeyer M; Timmermann L; van Eimeren T; Drzezga A; Eggers C
    Brain; 2020 Mar; 143(3):944-959. PubMed ID: 32057084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Population of Indirect Pathway Striatal Projection Neurons Is Selectively Entrained to Parkinsonian Beta Oscillations.
    Sharott A; Vinciati F; Nakamura KC; Magill PJ
    J Neurosci; 2017 Oct; 37(41):9977-9998. PubMed ID: 28847810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine D2 receptors in striatal output neurons enable the psychomotor effects of cocaine.
    Kharkwal G; Radl D; Lewis R; Borrelli E
    Proc Natl Acad Sci U S A; 2016 Oct; 113(41):11609-11614. PubMed ID: 27671625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Remodeling of the dendritic structure of the striatal medium spiny neurons accompanies behavioral recovery in a mouse model of Parkinson's disease.
    Kim W; Im MJ; Park CH; Lee CJ; Choi S; Yoon BJ
    Neurosci Lett; 2013 Dec; 557 Pt B():95-100. PubMed ID: 24176882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathway-Specific Remodeling of Thalamostriatal Synapses in Parkinsonian Mice.
    Parker PR; Lalive AL; Kreitzer AC
    Neuron; 2016 Feb; 89(4):734-40. PubMed ID: 26833136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modeling of presymptomatic and symptomatic stages of parkinsonism in mice.
    Ugrumov MV; Khaindrava VG; Kozina EA; Kucheryanu VG; Bocharov EV; Kryzhanovsky GN; Kudrin VS; Narkevich VB; Klodt PM; Rayevsky KS; Pronina TS
    Neuroscience; 2011 May; 181():175-88. PubMed ID: 21382448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parkinson's disease and pain: Modulation of nociceptive circuitry in a rat model of nigrostriatal lesion.
    Domenici RA; Campos ACP; Maciel ST; Berzuino MB; Hernandes MS; Fonoff ET; Pagano RL
    Exp Neurol; 2019 May; 315():72-81. PubMed ID: 30772369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations of the nigrostriatal pathway in a 6-OHDA rat model of Parkinson's disease evaluated with multimodal MRI.
    Perlbarg V; Lambert J; Butler B; Felfli M; Valabrègue R; Privat AL; Lehéricy S; Petiet A
    PLoS One; 2018; 13(9):e0202597. PubMed ID: 30188909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of unilateral lesion of the nigrostriatal dopamine pathway on survival and neurochemistry of parafascicular nucleus neurons in the rat--evaluation of time-course and LGR8 expression.
    Sedaghat K; Finkelstein DI; Gundlach AL
    Brain Res; 2009 May; 1271():83-94. PubMed ID: 19328193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of the lesion procedure on the profiles of motor impairment and molecular responsiveness to L-DOPA in the 6-hydroxydopamine mouse model of Parkinson's disease.
    Francardo V; Recchia A; Popovic N; Andersson D; Nissbrandt H; Cenci MA
    Neurobiol Dis; 2011 Jun; 42(3):327-40. PubMed ID: 21310234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.